Sanofi India is currently trading at Rs. 2950.00, up by 72.95 points or 2.54% from its previous closing of Rs. 2877.05 on the BSE.
The scrip opened at Rs. 2892.00 and has touched a high and low of Rs. 3050.00 and Rs. 2890.00 respectively. So far 668 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 3540.00 on 03-Jun-2014 and a 52 week low of Rs. 2280.00 on 05-Sep-2013.
Last one week high and low of the scrip stood at Rs. 3050.00 and Rs. 2850.00 respectively. The current market cap of the company is Rs. 6818.68 crore.
The promoters holding in the company stood at 60.40% while Institutions and Non-Institutions held 26.96% and 12.64% respectively.
Sanofi India has entered into a marketing and distribution agreement with Emcure Pharmaceuticals for its oncology portfolio in India. As per the agreement, while Sanofi will continue to own its oncology range - comprising 4 brands namely Taxotere, Jevtana, Fludara and Fasturtec, Emcure will market and distribute these brands through its Specialty Unit.
Sanofi, a global and diversified healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients’ needs. Sanofi has core strengths in the field of healthcare with seven growth platforms: diabetes solutions, human vaccines, innovative drugs, rare diseases, consumer healthcare, emerging markets and animal health.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1797.80 |
Dr. Reddys Lab | 1213.90 |
Cipla | 1486.30 |
Lupin | 2069.95 |
Zydus Lifesciences | 948.70 |
View more.. |